- Home
- IRON vs RNST Comparison
IRON vs RNST Comparison
Compare IRON & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- RNST
- Stock Information
- Founded
- IRON 2017
- RNST 1904
- Country
- IRON United States
- RNST United States
- Employees
- IRON N/A
- RNST N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- RNST Major Banks
- Sector
- IRON Health Care
- RNST Finance
- Exchange
- IRON Nasdaq
- RNST Nasdaq
- Market Cap
- IRON 1.9B
- RNST 2.2B
- IPO Year
- IRON N/A
- RNST N/A
- Fundamental
- Price
- IRON $52.23
- RNST $33.57
- Analyst Decision
- IRON Strong Buy
- RNST Buy
- Analyst Count
- IRON 10
- RNST 6
- Target Price
- IRON $83.80
- RNST $43.60
- AVG Volume (30 Days)
- IRON 342.1K
- RNST 675.5K
- Earning Date
- IRON 05-08-2025
- RNST 04-22-2025
- Dividend Yield
- IRON N/A
- RNST 2.48%
- EPS Growth
- IRON N/A
- RNST 27.73
- EPS
- IRON N/A
- RNST 3.27
- Revenue
- IRON N/A
- RNST $706,583,000.00
- Revenue This Year
- IRON N/A
- RNST $35.54
- Revenue Next Year
- IRON N/A
- RNST $20.29
- P/E Ratio
- IRON N/A
- RNST $10.85
- Revenue Growth
- IRON N/A
- RNST 14.55
- 52 Week Low
- IRON $25.60
- RNST $27.98
- 52 Week High
- IRON $68.73
- RNST $39.63
- Technical
- Relative Strength Index (RSI)
- IRON 44.88
- RNST 42.11
- Support Level
- IRON $51.57
- RNST $34.53
- Resistance Level
- IRON $53.61
- RNST $36.61
- Average True Range (ATR)
- IRON 2.00
- RNST 0.88
- MACD
- IRON 0.06
- RNST 0.15
- Stochastic Oscillator
- IRON 36.43
- RNST 39.71
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
About RNST Renasant Corporation
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: community banks, insurance, and wealth management. With its community banks segment, the company provides a range of financial services to individuals and small businesses. Its insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The wealth management segment provides a range of services including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment. Renasant Corporation operates in the southern United States.